Bristol-Myers raises buyout offer for ImClone to $4.7 billion

09/22/2008 | Forbes

Bristol-Myers Squibb announced that it is increasing its takeover offer for ImClone Systems to $62 per share, raising the value of the deal to $4.7 billion. In a letter to ImClone Chairman Carl Icahn, Bristol-Myers Chairman and CEO James Cornelius said delays in the transaction "have created a protracted period of uncertainty among our stockholders, employees and other constituents."

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC